CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$50.50 +0.62 (+1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) EV to EBITDA (2019 - 2022)

Updated

CRISPR Therapeutics AG's EV to EBITDA came in at 7.91 for Q1 2022, down 10.4% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) EV to EBITDA (2019 - 2022) Analysis & Trends

Over the trailing twelve months to Mar 31, 2022, CRISPR Therapeutics AG reported EV to EBITDA of -14.43; for FY2021, it was 8.83.

  • Going back by year, EV to EBITDA was 53.59 in FY2019.
  • Business Quant data shows CRSP's EV to EBITDA at 8.83 (Q4 2021), 14.28 (Q3 2021) and 21.18 (Q2 2021) in the three quarters before Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CRISPR Therapeutics AG 4.88 Bn -3.82 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 7.91
Dec 31, 2021 8.83
Sep 30, 2021 14.28
Jun 30, 2021 21.18
Jun 30, 2020 1,272.89
Mar 31, 2020 61.37
Dec 31, 2019 53.59
API Access

CRISPR Therapeutics AG EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CRSP&period=max&api_key=YOUR_API_KEY